Today, six biofuel trade associations sent a letter to House and Senate leaders asking Congress for a multiyear extension of advanced biofuel tax credits. 

The Biotechnology Innovation Organization (BIO) is pleased to announce that Europe’s largest cluster of bioeconomy companies, IAR, will be a top supporting organization of BIO’s 13th Annual World Congress on Industrial Biotechnology. 

The Biotechnology Innovation Organization (BIO) announced today that President and CEO of NexSteppe, Anna Rath, has been selected by a committee of her peers to be the recipient of the 2016 BIO Rosalind Franklin Award. 

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the American College of Physicians’ policy paper on prescription drugs.

The Biotechnology Innovation Organization (BIO) in partnership with the National Science Foundation (NSF) will feature Small Business Innovation Research (SBIR) funded early-stage industrial biotech companies at BIO’s 13thAnnual World Congress on Industrial Biotechnology.  

The Biotechnology Innovation Organization (BIO) announces that executives, thought leaders, and government  officials will discuss applications in space, biofuels, and the renewable chemical landscape during plenary programs at BIO’s 13th Annual World Congress on Industrial Biotechnology

The Biotechnology Innovation Organization (BIO) has officially named Dr. J. Craig Venter as the recipient of its 2016 George Washington Carver Award for innovation in industrial biotechnology. 

The Biotechnology Innovation Organization (BIO) today applauded Iowa’s Senate for approving a new five-year production tax credit for renewable chemicals and helping to drive innovation in this new sector. Renewable chemicals will be defined in Iowa’s tax code as having at least 50 percent biobased content and not being used as food, feed or fuel. The value of the tax credit is limited to $105 million over five years.

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act:

The Biotechnology Innovation Organization (BIO) andKentucky Life Sciences Council (KLSC) today voiced support for Kentucky Senate Bill 134, legislation that properly preserves patient and physician access to accurate prescription information, while promoting a competitive market for complex biologic medicines.